BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6496258)

  • 1. Action of vitamin P like compounds on lysosomal fragility in hypercholesterolemia: implication of ascorbic acid and its metabolites.
    Rathi AB; Nath N; Chari SN
    Acta Vitaminol Enzymol; 1984; 6(2):97-102. PubMed ID: 6496258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action of vitamin P like compounds on lysosomal status in hypercholesterolemic rats.
    Rathi AB; Nath N; Chari SN
    Acta Vitaminol Enzymol; 1983; 5(4):255-61. PubMed ID: 6673577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effect of certain compounds on the lysosomal release of polymorphonuclear leukocytes.
    Chari SN; Nath N; Rathi AB
    Indian J Physiol Pharmacol; 1983; 27(3):227-33. PubMed ID: 6668054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol lowering action of vitamin P-like compounds in rats.
    Basarkar PW; Nath N
    Indian J Exp Biol; 1981 Aug; 19(8):787-9. PubMed ID: 7309166
    [No Abstract]   [Full Text] [Related]  

  • 5. Factor(s) responsible for hepatic lysosomal release in normal and hypercholesterolemic states.
    Rathi AB; Nath N; Chari SN
    Indian J Biochem Biophys; 1984 Dec; 21(6):402-5. PubMed ID: 6545532
    [No Abstract]   [Full Text] [Related]  

  • 6. Action of bioflavonoids on lipid peroxidation & glutathione redox system in hypercholesterolemic rats.
    Rathi AB; Nath N; Chari SN
    Indian J Med Res; 1984 Apr; 79():508-13. PubMed ID: 6490114
    [No Abstract]   [Full Text] [Related]  

  • 7. Intracellular accumulation of ascorbic acid is inhibited by flavonoids via blocking of dehydroascorbic acid and ascorbic acid uptakes in HL-60, U937 and Jurkat cells.
    Park JB; Levine M
    J Nutr; 2000 May; 130(5):1297-302. PubMed ID: 10801933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some studies on ascorbic acid metabolism in hydrazine-treated rats.
    Sengupta K; Chatterjee AK; Ghosh B
    Int J Vitam Nutr Res; 1978; 48(2):152-8. PubMed ID: 689810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of flavonoids on vitamin C activity of D-isoascorbic acid.
    Zloch Z; Ginter E
    Physiol Bohemoslov; 1979; 28(6):519-24. PubMed ID: 160573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of bioflavonoids on lysosomal acid hydrolases and lysosomal stability.
    Rao CN; Rao VH; Steinmann B
    Ital J Biochem; 1981; 30(1):46-53. PubMed ID: 7251340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzymatic basis for altered ascorbic acid and dehydroascorbic acid levels in diabetes.
    Bode AM; Yavarow CR; Fry DA; Vargas T
    Biochem Biophys Res Commun; 1993 Mar; 191(3):1347-53. PubMed ID: 8466510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ascorbic acid in thyroidectomized rats. I) Biosynthesis and catabolism.
    Nath N; Nath M; Muddeshwar MG
    Acta Vitaminol Enzymol; 1984; 6(2):83-9. PubMed ID: 6496257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efflux of hepatic ascorbate: a potential contributor to the maintenance of plasma vitamin C.
    Upston JM; Karjalainen A; Bygrave FL; Stocker R
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):49-56. PubMed ID: 10432299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vivo cytoprotection of ascorbic acid against ischemia/reoxygenation injury of rat liver.
    Ozaki M; Fuchinoue S; Teraoka S; Ota K
    Arch Biochem Biophys; 1995 Apr; 318(2):439-45. PubMed ID: 7733675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of alcohol intoxication on ascorbic and dehydroascorbic acid levels in rat tissue. and human blood].
    Shugaleĭ IuS; Degtiar VV; Butvin IN; Grivenko GP
    Ukr Biokhim Zh (1978); 1986; 58(3):81-3. PubMed ID: 3727042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of anabolic substances on the state of the individual components of the glutathione-ascorbic acid system].
    Kuzdenbaeva RS; Kurakina VE; Iztleuov MK
    Farmakol Toksikol; 1980; 43(5):607-9. PubMed ID: 7449993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulating effect by zinc on hepatic lysosomal fragility induced by surface-active agents.
    Pfeiffer CJ; Cho CH
    Res Commun Chem Pathol Pharmacol; 1980 Mar; 27(3):587-98. PubMed ID: 7384647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum beta-glucuronidase reflects hepatic lysosomal fragility following toxic liver injury in rats.
    George J
    Biochem Cell Biol; 2008 Jun; 86(3):235-43. PubMed ID: 18523484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Content of different forms of ascorbic acid in the tissues of rabbits with experimental myocardial infarct].
    Khmelevskiĭ IuV; Gladchuk AB
    Vopr Pitan; 1981; (4):41-3. PubMed ID: 7293105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orange-peel flavonoids and the growth and ascorbic acid status of hypovitaminotic C guinea-pigs [proceedings].
    Wilson HK; Hassall C; Price Jones C; Hughes RE
    Proc Nutr Soc; 1976 Dec; 35(3):120A-121A. PubMed ID: 1028053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.